Skip to main content
. 2015 Jun 15;10(6):e0129566. doi: 10.1371/journal.pone.0129566

Fig 1. Combined effect of TRAIL and doxorubicin in prostate carcinoma PPC-1 cells.

Fig 1

PPC-1 cells grown to subconfluency in 384 well plate were treated with TRAIL (0.1 ng/ml) and increasing concentrations of doxorubicin. The level of cytotoxicity was determined by an ATPLite reagent. T, TRAIL; Dox. doxorubicin. P < 0.01.